Related Experiment Video
Updated: Jun 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1
David Z I Cherney1, Judith A Miller, James W Scholey
1Division of Nephrology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. david.cherney@uhn.on.ca
Objective:
Our aim was to examine the effect of cyclooxygenase 2 (COX2) inhibition on endothelial function in subjects with type 1 diabetes analyzed on the basis of renal filtration status.
Research Design And Methods:
Flow-mediated dilation (FMD) was determined in type 1 diabetic subjects and hyperfiltration (glomerular filtration rate >or=135 ml/min/1.73 m(2), n = 13) or normofiltration (glomerular filtration rate >or=135 ml/min/1.73 m(2), n = 11). Studies were performed before and after celecoxib (200 mg daily for 14 days) during euglycemia and hyperglycemia.
Results:
Baseline parameters were similar in the two groups. Pretreatment, FMD was augmented in normofiltering versus hyperfiltering subjects during clamped euglycemia (10.2 +/- 5.3% vs. 5.9 +/- 2.3%, P = 0.003). COX2 inhibition suppressed FMD in normofiltering (10.2 +/- 5.3% to 5.8 +/- 3.4%, P = 0.006) versus hyperfiltering subjects (ANOVA interaction, P = 0.003).
Conclusions:
Systemic hemodynamic function, including the response to COX2 inhibition, is related to filtration status in diabetic subjects and may reflect general endothelial dysfunction.
Insights
Cyclooxygenase 2 (COX2) inhibition impacts endothelial function differently in type 1 diabetes patients based on their renal filtration status, suggesting broader endothelial dysfunction.
Area of Science:
- Cardiovascular Research
- Nephrology
- Endocrinology
Background:
- Endothelial dysfunction is a key complication in type 1 diabetes.
- Renal hyperfiltration is a marker of early kidney damage in diabetes.
- The role of cyclooxygenase 2 (COX2) in diabetic endothelial function requires further elucidation.
Purpose of the Study:
- To investigate the effect of COX2 inhibition on endothelial function in type 1 diabetes.
- To analyze these effects based on the renal filtration status (hyperfiltration vs. normofiltration).
Main Methods:
- Flow-mediated dilation (FMD) was measured in type 1 diabetic subjects with hyperfiltration (GFR ≥135 ml/min/1.73 m²) and normofiltration (GFR <135 ml/min/1.73 m²).
- Studies were conducted before and after a 14-day course of celecoxib (200 mg daily).
- Measurements were performed under both euglycemic and hyperglycemic conditions.
Main Results:
- Baseline FMD was significantly higher in normofiltering subjects compared to hyperfiltering subjects during euglycemia.
- COX2 inhibition with celecoxib markedly suppressed FMD in normofiltering individuals.
- Conversely, COX2 inhibition had a less pronounced effect on FMD in hyperfiltering subjects, indicating an interaction with filtration status.
Conclusions:
- Endothelial function response to COX2 inhibition in type 1 diabetes is significantly influenced by renal filtration status.
- These findings suggest that filtration status may reflect underlying, generalized endothelial dysfunction in diabetic patients.
- Targeting COX2 pathways may have differential effects on vascular health depending on diabetic nephropathy progression.
Related Concept Videos
Diabetic Nephropathy
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics
Hyperglycemia
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Hypertension and Regulation of Blood Pressure